Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma
Wenzhe Fan,
Bowen Zhu,
Shuling Chen
et al.
Abstract:ImportanceTransarterial chemoembolization (TACE) is commonly used to treat patients with recurrent intermediate-stage hepatocellular carcinoma (HCC) and positive microvascular invasion (MVI); however, TACE alone has demonstrated unsatisfactory survival benefits. A previous retrospective study suggested that TACE plus sorafenib (SOR-TACE) may be a better therapeutic option compared with TACE alone.ObjectiveTo investigate the clinical outcomes of SOR-TACE vs TACE alone for patients with recurrent intermediate-st… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.